GHCM
BLUE

Glen Harbor Capital Management’s bluebird bio BLUE Stock Holding History

Glen Harbor Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-473
Closed -$895K – 1289
2018
Q3 		$895K Sell
473
-167
-26% -$345K 0.02% 510
2018
Q2 		$1.3M Sell
640
-95
-13% -$217K 0.03% 378
2018
Q1 		$1.63M Sell
735
-216
-23% -$549K 0.04% 318
2017
Q4 		$2.19M Sell
951
-151
-14% -$307K 0.05% 281
2017
Q3 		$1.96M Sell
1,102
-59
-5% -$82.4K 0.05% 291
2017
Q2 		$1.58M Buy
1,161
+65
+6% +$78.4K 0.04% 332
2017
Q1 		$1.29M Hold
1,096
– – 0.03% 367
2016
Q4 		$876K Buy
+1,096
New +$870K 0.02% 390

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glen Harbor Capital Management's BLUE Position: Q4 2018 in Review

Glen Harbor Capital Management sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 473 shares — an estimated $895K sold.

Glen Harbor Capital Management first reported a position in BLUE in Q4 2016 and held it in 8 quarters. The position peaked at $2.19M in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Glen Harbor Capital Management reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Glen Harbor Capital Management sold 473 bluebird bio shares in Q4 2018, an estimated $895K.
  • Glen Harbor Capital Management first reported a position in bluebird bio in Q4 2016 and held it in 8 quarters.
  • Glen Harbor Capital Management's bluebird bio position peaked at $2.19M in Q4 2017.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Glen Harbor Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.